Beauty can be expensive to buy in a jar. When we do buy an anti-aging cream, we expect the manufacturer’s claims to be tested and true -- especially at $100 for a 0.5 to 1.7 ounce container.
L’Oreal was sent a warning letter from the Food and Drug Administration on Sept 7, 2012 to stop advertising their Lancome skin care products in a manner that made them sound like drugs.
According to CBSnews.com, Lancome describes the Genifique Repair, which costs $98 for a 1.7-ounce container, as "our first night care that boosts the activity of genes."
Lancome claims to have tested their product with “in vitro tests on genes” on their website.
The FDA letter addressed other Lancome products that make “medical” sounding claims such as their Absolue line that states “has been shown to improve the condition around the stem cells and stimulate cell regeneration to reconstruct skin to a denser quality.”
Absolue Eye Precious Cells Advanced Regenerating and Reconstructing Eye Cream costs $108 for 0.5 ounces.
The FDA stated in their letter that products that claim they can affect the structure or function of human cells renders them as behaving like drugs. This makes L’Oreal in violation with the Act that regulates how drugs are allowed to come to market.
Drugs can only gain FDA approval after going through an elaborate process of research and clinical trials, which takes years. Cosmetics are regulated less strictly than drugs because the FDA is only concerned with their safety, not effectiveness, Mayoclinic.com explained.
L’Oreal was warned to comply and take prompt action within 15 working days to revise their advertising or to inform the FDA as to why they feel they are not in violation.
Rebecca Caruso, a L'Oreal spokeswoman, responded by saying, "Lancome is committed to complying fully with all laws and regulatory standards."
L’Oreal was not the only company to receive a warning letter that they were in violation of the Act.